Aehr Test Systems (AEHR) Cash & Equivalents (2010 - 2026)

Aehr Test Systems has reported Cash & Equivalents for 17 years, with the latest figure at $36.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 25.5% year-over-year to $36.9 million; the trailing twelve-month figure through Feb 2026 stood at $36.9 million (up 25.5% YoY), and the FY2025 full-year result was $24.5 million, down 50.1% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $36.9 million, up from $30.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $51.0 million in Q3 2023, with the low at $17.2 million in Q1 2023.
• Historically, Cash & Equivalents has averaged $34.0 million across 5 years, with a median of $32.0 million in 2022.
• Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 587.12% — and 2025, when it slumped 50.1%.
• Aehr Test Systems' Cash & Equivalents stood at $18.9 million in 2022, then soared by 167.64% to $50.5 million in 2023, then tumbled by 36.22% to $32.2 million in 2024, then declined by 4.29% to $30.8 million in 2025, then increased by 19.7% to $36.9 million in 2026.
• The last three Cash & Equivalents figures came in at $36.9 million (Q1 2026), $30.8 million (Q4 2025), and $22.7 million (Q3 2025), per Business Quant data.